Skip to content

Company information lookup

CELLMID LIMITED (CDY)

Developer of products to treat various cancers and chronic inflammatory diseases

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
CDY 0.028 0% 0.028 0.030 0.000 0.000 0.000 0

CELLMID LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code CDY
Securities
Official Listing Date 9 December, 2005
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.cellmid.com.au
Registered Office Address Suite 1802, Level 18, 15 Castlereagh Street, SYDNEY, NSW, AUSTRALIA, 2000
Head Office Telephone (02) 9221 6830
Head Office Fax (02) 9221 8535
Share Registry BOARDROOM PTY LIMITED
LEVEL 7, 207 KENT STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone (02) 9290 9600
Directors / Senior Management
Dr David King (Chairman, Non Exec. Director)
Ms Maria Julianna Halasz, BSc, MBA (Managing Director, CEO)
Mr Graeme Kaufman (Non Exec. Director)
Mr Martin Rogers (Non Exec. Director)
Company Secretary Ms Jillian McGregor
Mr Nicholas Falzon
Principal Activities Developer of products to treat various cancers and chronic inflammatory diseases

CELLMID LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
19/09/2014   Change of Director's Interest Notice 3 PDF
16/09/2014   Annual Report to shareholders 2014 78 PDF
08/09/2014   Notice of Annual General Meeting and Proxy Form 17 PDF
29/08/2014 asterix Appendix 4E and Preliminary Final Report 61 PDF
20/08/2014   Date of Annual General Meeting 1 PDF
18/08/2014   Cellmid Newsletter 8 PDF
15/08/2014   Cleansing Notice and Appendix 3B 10 PDF
29/07/2014 asterix Appendix 4C - quarterly 6 PDF
16/07/2014 asterix Cellmid Granted UK Patent for Use of Midkine for Hair Growth 2 PDF
15/07/2014 asterix Landmark Study- FGF5 Critical Regulator of Human Hair Growth 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
01 Oct 2014 0.028 0% 0.028 0.028 341,131
30 Sep 2014 0.028 0% 0.029 0.028 975,000
29 Sep 2014 0.028 0% 0.029 0.028 501,416
26 Sep 2014 0.028 -6.67% 0.030 0.028 578,209
25 Sep 2014 0.030 3.45% 0.030 0.029 1,251,000

* Volume of shares shown represents only those shares traded on ASX.

CELLMID LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security CDY. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security CDY

Warrants & Structured Products

No warrants & Structured Products are available over the security CDY